Hoth Therapeutics Inc

NASDAQ HOTH

Data sourced from iex and EODHD
Download Data

Hoth Therapeutics Inc Income Statement 2018 - 2024

This table shows the Income Statement for Hoth Therapeutics Inc going from 2018 until 2024. The income statement, also known as the profit and loss statement, is a financial statement that provides a summary of a company's revenues, expenses, and net income over a specific period (such as a quarter or a year). It shows the company's ability to generate revenue, manage expenses, and ultimately determine its profitability.
Income Statement Trend Unit 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31
Revenue
M 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Cost of Revenue
M - 0 0 0 0 0 0 0 0 47 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Gross Profit
M - 0 0 0 0 0 0 0 0 -47 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Operating Expenses
M - 2 2 2 2 3 3 2 3 -43 3 3 4 1 2 3 2 4 2 1 1 1 1 1 1
Selling, General, and Administrative Expenses (SG&A)
M 2 1 1 1 1 2 1 1 1 1 1 1 2 1 1 1 1 3 1 1 0 0 0 0 0
Research and Development (R&D) Expenses
M 0 1 1 1 1 1 1 1 1 2 2 2 2 0 1 1 1 1 1 0 0 0 0 0 0
Other Operating Expenses
M - 0 0 0 0 0 0 0 0 -47 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Costs and Expenses
M - 2 2 2 2 3 3 2 3 -43 3 3 4 1 2 3 2 4 2 1 1 1 1 1 1
Operating Income
M -2 -2 -2 -2 -2 -3 -3 -2 -3 -3 -3 -3 -4 -1 -2 -3 -2 -4 -2 -1 -1 -1 -1 -1 -1
Interest Expense
M - 0 - - 0 0 0 0 0 0 - - - - - - - - - - 0 0 - - -
Non-operating Income/Expense
M 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 - 0 0 0 0 0
EBT
M -2 -2 -2 -2 -2 -3 -3 -3 -3 -3 -3 -3 -4 -1 -2 -2 -2 -4 -2 -1 0 0 -1 -1 -1
Income Tax Provision
M -2 0 - - 0 0 0 0 0 0 - - - - - - - 0 - - - 0 0 0 0
Income after Tax
M 0 -2 - - -2 -4 -3 -3 -2 -4 - - - - - - - -4 - - - 0 -1 -1 -1
Non-Controlling Interest
M - - - 0 0 -2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Net Income
M - - - -2 -2 -2 -3 -3 -3 -3 -3 -3 -4 -1 -2 -2 -2 -4 -2 -1 -1 -1 -1 -1 -1
Shares (Basic, Weighted)
M - - - - - - - - - - - - - - - - - - - - - - - - -
Shares (Diluted, Weighted)
R 4,398,909.00 4,348,129.00 3,483,735.00 3,302,113.00 2,482,824.00 1,197,521.00 1,288,481.00 1,241,368.00 958,993.00 893,226.00 955,538.00 947,779.00 707,097.00 494,513.00 537,395.00 492,170.00 410,042.00 366,583.00 395,470.00 384,125.00 376,982.00 9,424,574.00 376,982.00 376,982.00 376,982.00
EBITDA
M -2 -2 -2 -2 -2 -3 -3 -2 -3 -3 -3 -3 -4 -1 -2 -3 -2 -4 -2 -1 -1 -1 -1 -1 -1
Depreciation and Amortization
M 2 0 0 0 0 0 0 0 0 0 0 - 0 0 0 0 0 0 0 0 0 0 0 0 0
EBIT
M -4 -2 -2 -2 -2 -3 -3 -2 -3 -3 -3 -3 -1 -1 -2 -3 -2 -4 -2 -1 -1 -1 -1 -1 -1
Income from Discontinued Operations
M - - - - - - - - - - - - - - - - - - - - - - - - -
Tax Rate (Effective)
% 100.66 0.10 - - 0.43 -9.93 1.52 -14.12 3.47 -2.87 - - - - - - - 0.00 - - - 0.00 0.00 0.00 0.00
Earnings Per Share (EPS), Basic
M - - - - - - - - - - - - - - - - - - - - - - - - -
Earnings Per Share (EPS), Diluted
M - - - 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Gross Profit Margin
% - 50.00 - - - - - - - - - - - - - - - - - - - - - - -
Operating Income Margin
% - -2,851.66 - - - - - - - - - - - - - - - - - - - - - - -
Net Income Margin
% - - - - - - - - - - - - - - - - - - - - - - - - -
EBITDA Ratio
% - -2,851.66 - - - - - - - - - - - - - - - - - - - - - - -
EBIT Ratio
% - -2,854.51 - - - - - - - - - - - - - - - - - - - - - - -
EBT Ratio
% - -2,859.13 - - - - - - - - - - - - - - - - - - - - - - -

StockViz Staff

September 16, 2024

Any question? Send us an email